Background: Luteolin has been demonstrated to possess numerous biological effects. However, the effect of luteolin on LPS (Lipopolysaccharides) stimulation in CPEK cells has not been investigated. Hypothesis/Objectives: An in vitro model of atopic canine dermatitis was used to identify the antioxidant effect of luteolin as a new treatment that is capable of improving the conditions of veterinary patients. Methods: CPEK cells were treated with or without luteolin in the presence or absence of LPS. A cell viability assay was performed to test luteolin toxicity and the protective effect of luteolin after LPS stimulation. Additionally, enzyme-linked immunosorbent assay (ELISA) kits were used to detect the levels of IL-33, IL-1β, IL-6, and IL-8. Results: Luteolin was capable to significantly decrease levels expression of IL-33, IL 1β, IL-6, and IL-8. Conclusions and clinical importance: Luteolin could be a new pharmacological treatment for canine atopic dermatitis.
Canine atopic dermatitis: role of luteolin as new natural treatment
Gugliandolo, EnricoPrimo
;Cordaro, Marika;D’Amico, Ramona;Peritore, Alessio Filippo;Licata, PatriziaPenultimo
;Crupi, Rosalia
Ultimo
2020-01-01
Abstract
Background: Luteolin has been demonstrated to possess numerous biological effects. However, the effect of luteolin on LPS (Lipopolysaccharides) stimulation in CPEK cells has not been investigated. Hypothesis/Objectives: An in vitro model of atopic canine dermatitis was used to identify the antioxidant effect of luteolin as a new treatment that is capable of improving the conditions of veterinary patients. Methods: CPEK cells were treated with or without luteolin in the presence or absence of LPS. A cell viability assay was performed to test luteolin toxicity and the protective effect of luteolin after LPS stimulation. Additionally, enzyme-linked immunosorbent assay (ELISA) kits were used to detect the levels of IL-33, IL-1β, IL-6, and IL-8. Results: Luteolin was capable to significantly decrease levels expression of IL-33, IL 1β, IL-6, and IL-8. Conclusions and clinical importance: Luteolin could be a new pharmacological treatment for canine atopic dermatitis.File | Dimensione | Formato | |
---|---|---|---|
Veterinary Medicine Sci - 2020 - Gugliandolo - Canine atopic dermatitis Role of luteolin as new natural treatment.pdf
accesso aperto
Tipologia:
Versione Editoriale (PDF)
Licenza:
Creative commons
Dimensione
558.45 kB
Formato
Adobe PDF
|
558.45 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.